News
Dr. Echegoyen Participated in Clinical Trials for the First Major Phacoemulsification Advancement in Over 15 YearsSan Diego, CA, June 25, 2025 (GLOBE NEWSWIRE) -- Gordon Schanzlin New Vision Institute ...
1d
Sportschosun on MSN77.3% of seniors experience cataract surgery, making daily life easierEvery June is Cataract Awareness Month. It is a communication month designated by seniors over 50 and their families, medical ...
LOS ANGELES — With the recently launched Unity system, Alcon aims to allow ophthalmologists to perform vitreoretinal cataract surgery and cataract surgery on the same platform. According to a ...
In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix Pro, the ...
Alcon posts steady growth in Vision Care and Surgical, with new drug and therapy launches ahead but execution risks persist. Read why ALC stock is a hold.
It is projected to increase from $4.06 billion in 2024 to $4.35 billion in 2025, indicating a compound annual growth rate CAGR of 7.0%. The growth in the historic period can be attributed to factors ...
In the transforming political and administrative scenario of the Bodoland Territorial Region (BTR), Raju Dhakal, the current ...
What is ultraviolet light, and where does it come from? Learn how UV radiation is classified, measured, and used in medicine, ...
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the ...
After operating as a Novartis subsidiary for eight years, Alcon split from the Swiss pharma giant in 2019. Since then, Alcon has been on a growth splurge. Related.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results